Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.

Multiple sclerosis: meeting unmet needs through scientific discoveries and clinical practice

PART OF MS Alumni FEATURE
Multiple sclerosis: meeting unmet needs through scientific discoveries and clinical practice
  • Neurology
  • Multiple sclerosis
International conference by Excemed
Saturday, Apr 9 - Sunday, Apr 10 2016
Berlin, Germany

Tags

multiple sclerosis

Language

English

Registration status
Closed

To register for this event, contact

Meridiano Congress International (Italy)
Congress Manager: David H. Slangen
T +39 06 88 595 250 - F +39 06 88 595 234
david.slangen@meridiano.it

Registration fee

400.00€

Introduction

Overview

Several advances have been made from the clinico-diagnostic, scientific and therapeutic points of view in the multiple sclerosis (MS) field over the past few years. Although new opportunities have been offered to MS patients, new issues are concerning the MS community. Among them, the need to better define therapeutic algorithms and to balance risks and benefits related to the new disease modifying drugs (DMDs) are still of pivotal importance. If the relapsing-remitting phase of MS can benefit from the new DMDs, an effective treatment for the progressive forms is still lacking. Therefore, basic scientists and clinicians have put great effort into trying to better understand the pathogenic mechanisms underlying progressive MS and discover new potential therapeutic targets. The programme will offer a comprehensive overview of MS pathophysiology, diagnosis and treatment as well as give participants the most up-to-date information in basic science, diagnostic workout, clinical management and risk stratification in order to globally improve the lives and health care of MS patients.

Learning objectives

• Describe the main advances in MS pathogenesis

• Discuss the role of different tools in MS diagnosis, monitoring and treatment choices

• Review the mechanisms of neurodegeneration and repair

Accreditation details

EXCEMED  (www.excemed.org)  is  accredited  by  the  European  Accreditation  Council  for  Continuing Medical  Education  (EACCME ® )  to  provide  the  following  CME  activity  for  medical  specialists.  The EACCME ® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net

The  CME  conference “Multiple  sclerosis:  meeting  unmet  needs  through  scientific  discoveries  and clinical practice” to be held on 9-10 April 2016 in Berlin, Germany, is designated for a maximum of 9 (nine) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized by the American
Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.

An application for CME accreditation has been made to the Medical Association Berlin (Ärztekammer Berlin).

MS Alumni

The MS Alumni programme is an educational initiative of EXCEMED that is intended to provide ongoing support for young physicians and specialists in neurology.

Scientific programme

Scientific programme

 

DAY 1

08.45                     EXCEMED opening, D. Bates (UK) – G. Comi (Italy)

Real-time survey

SESSION I: Update on pathogenesis

09.00 L1:              Revisiting the role of T and B cells in MS, A. Bar - Or (Canada)

09.20 L2:              Variability of MS evolution: the role of genetics and environment, D. Hafler (USA)

09.40 L3:              Basic mechanisms of underlying  disease “progression”, H. Lassman (Austria)

Discussion

10.20                     Coffee break

 

SESSION II - MS treatment

10.50 L4:              Risk minimization, P.S. Sorensen (Denmark)

11.10 L5:              MRI as a guide for treatment decisions, N. De Stefano (Italy)

11.30 L6:              Visual platforms in clinical trials and patient monitoring, P.Villoslada (Spain)

11.50 L7:              How the lab could monitor burden of CD4 and CD5, M. Comabella (Spain)

Discussion

Revisiting real-time survey

12.30                     Lunch

Real-time survey

SESSION III -MS treatment

13.30 L8:              Methodological aspects in comparing treatment efficacy, L. Kappos (Switzerland)

13.50 L9:              How to assess treatment response, M. Tintorè (Spain)

14.10 L10:            Revisited induction, G. Comi (Italy)

14.50                     Snapshots:

  • Current and emerging treatments, A. Chan (Switzerland)
  • Emerging MRI techniques and their relationship  to clinical outcomes, J. Oh (Canada)
  • Managing immunosuppression, S. Schippling (Switzerland)

15.20:                   Coffee break

SESSION IV - Recovery and rehabilitation

15.50 L11:            Myelin repair, S. Bittner (Germany)

16.10 L12:            Pharmacology for enhanced recovery, D. Centonze (Italy)

16.30 L13:            New basis for rehabilitation, J. Kesselring (Switzerland)

Discussion

Revisiting real-time survey

17.10                     End of the day

DAY 2

08.30-10.30

WS1: Instrumental techniques

  • MRI – N. De Stefano (Italy)
  • Functional tests (VEP) – L. Leocani (Italy)

WS2: Decision making process

  • M. Tintorè (Spain)
  • G. Comi (Italy)

WS3: Symptomatic treatments

  • J. Kesselring (Switzerland)
  • P.S. Sørensen (Denmark)

WS4: Fluids biomarkers

  • A. Bar ‘Or (Canada)
  • L. Kappos (Switzerland)

10.30-11.00 Coffee break

11.00-11.30 Gauging your knowledge and views

11.30-12.00 CLOSING PLENARY LECTURE - New challenges and new frontiers: the PMSA experience, A. J. Thompson (UK)

12.00 Wrap up

12.10 End of the conference

CME provider

EXCEMED - Excellence in Medical Education

EXCEMED is a non profit foundation dedicated, since the last four decades, to the development of high-quality medical education programme all over the world. EXCEMED adheres to the guidelines and standards of the European Accreditation Council for Continuing Medical Education (EACCME ® ) which states that continuing medical education must be balanced, independent, objective, and scientifically rigorous.

Chair(s)

David Bates

Department of Neurology
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom

Giancarlo Comi

Department of Neurology
Institute of Experimental Neurology
Vita-Salute San Raffaele University
Milan, Italy
Speakers

Amit Bar-Or

Neurologist and Professor
Department of Neurology and Neurosurgery
Clinical Research Unit
Montreal Neurological Institute
Montreal, Canada

David Bates

Department of Neurology
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom

Stefan Bittner

Department of Neurology
University of Muenster
Muenster, Germany

Diego Centonze

Neurology Unit
IRCSS Mediterraneo Neuromed Neurology Institute
Rome, Italy

Andrew Chan

St. Joseph Hospital der Ruhr
Bochum, Germany

Manuel Comabella

Multiple Sclerosis Center of Catalonia Unit of Clinical Neuroimmunology
Vall d’Hebron University Hospital
Barcelona, Spain

Giancarlo Comi

Department of Neurology
Institute of Experimental Neurology
Vita-Salute San Raffaele University
Milan, Italy

Nicola De Stefano

Department of Medicine, Surgery & Neuroscience
University of Siena
Siena, Italy

David Hafler

Department of Neurology
Yale School of Medicine
New Haven, United States

Ludwig Kappos

Department of Biomedicine
University Hospital Basel
Basel, Switzerland

Jürg Kesselring

Head of Department of Neurology & Neurorehabilitation
Department of Neurorehabilitation
Valens Clinic Rehabilitation Centre
Valens, Switzerland

Hans Lassman

Department of Neuroimmunology
Medical University of Vienna
Vienna, Austria

Letizia Leocani

Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy

Jiwon Oh

Division of Neurology
University of Toronto
Canada

Sven Schippling

CRPP Multiple Sclerosis
University of Zurich
Zurich, Switzerland

Alan Thompson

Department of Brain Repair and Rehabilitation
Institute of Neurology
National Hospital for Neurology and Neurosurgery
Queen Square
London, United Kingdom

Mar Tintorè

Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain

Pablo Villoslada

Dept of Neurology
University of California San Francisco
San Francisco (CA), United States
Slide kit
Amit Bar-Or
Neurology
Slide kit
Stefan Bittner
Neurology
Stefan Bittner
Neurology
Slide kit
Diego Centonze
Neurology
Slide kit
Andrew Chan
Neurology
Slide kit
Manuel Comabella
Neurology
Manuel Comabella
Neurology
Slide kit
Giancarlo Comi
Neurology
Slide kit
Giancarlo Comi
Neurology
Giancarlo Comi
Neurology
Slide kit
Nicola De Stefano
Neurology
Slide kit
Nicola De Stefano
Neurology
Video
Nicola De Stefano
Neurology
Jürg Kesselring
Neurology
Slide kit
Jürg Kesselring
Neurology
Slide kit
Jürg Kesselring
Neurology
Slide kit
Letizia Leocani
Neurology
Slide kit
Sven Schippling
Neurology
Video
Per Sorensen
Neurology
Slide kit
Per Soelberg Sørensen
Neurology
Slide kit
Per Soelberg Sørensen
Neurology
Slide kit
Pablo Villoslada
Neurology